Sunesis Pharmaceuticals to Report First Quarter 2006 Financial Results May 4, 2006
April 28 2006 - 8:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., April 28 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics, today
announced that Sunesis senior management will hold an investor
conference call to discuss financial results for the first quarter
2006 on Thursday, May 4, 2006 at 8:00 a.m. PDT/11:00 a.m. EDT.
Individual and institutional investors can access the call via
866-558-6338 (U.S. and Canada) or 213-785-2437 (international). To
access the live audio broadcast or the subsequent archived
recording, visit the "Investors and Media -- Calendar of Events"
section of the Sunesis website at http://www.sunesis.com/. Please
log on to Sunesis' website several minutes prior to the start of
the presentation to ensure adequate time for any software download
that may be necessary. About Sunesis Pharmaceuticals Sunesis is a
clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of novel small molecule
therapeutics for oncology and other serious diseases. Sunesis has
built a broad product candidate portfolio through internal
discovery and in-licensing of novel cancer therapeutics. Sunesis is
advancing its product candidates through in-house research and
development efforts and strategic collaborations with leading
pharmaceutical and biopharmaceutical companies. For further
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/. Forward-Looking Statements This press
release may contain forward-looking statements that involve
substantial risks and uncertainties. Sunesis may not actually
achieve the plans, intentions or expectations contained in such
forward-looking statements. Actual results or events could differ
materially from the plans, intentions and expectations contained in
such forward-looking statements. Sunesis does not assume any
obligation to update any such forward-looking statements.
DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: investors, Eric
Bjerkholt, CFO of Sunesis Pharmaceuticals, Inc., +1-650-266-3717;
or media, Karen L. Bergman or Michelle Corral, +1-650-575-1509, or
+1-415-794-8662, both of BCC Partners, for Sunesis Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles